Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 11Pain, Postoperative 10Agnosia 6Stomach Neoplasms 4Prostatic Neoplasms 4Pain 4Lung Neoplasms 4Neoplasms 3Postoperative Complications 2Colonic Neoplasms 2Uterine Cervical Neoplasms 1Thyroid Neoplasms 1Supratentorial Neoplasms 1Sleep Deprivation 1Sarcoma 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Ovarian Cysts 1Neuroblastoma 1Neoplasm Metastasis 1Meningioma 1Malignant Neoplasms of Male Genital Organs 1Leiomyoma 1Intraoperative Complications 1Goiter 1Ganglion Cysts 1Fallopian Tube Neoplasms 1Esophageal Neoplasms 1Endometrial Neoplasms 1Emergence Delirium 1

Interventions

estradiol, norethindrone drug combination 9asoprisnil 9Uterine Myomectomy 9telapristone acetate 8Uterine Artery Embolization 8ulipristal acetate 7relugolix 7elagolix 7Estradiol 7vilaprisan 5Norethindrone Acetate 5Mifepristone 5ulipristal 4linzagolix 4Leuprolide 4Tranexamic Acid 3Sodium Chloride 3Hysterectomy 3Gonadotropin-Releasing Hormone 3Embolization, Therapeutic 3cetrorelix 2Saline Solution 2Radiofrequency Ablation 2Progestins 2Lidocaine 2Letrozole 2Goserelin 2Endometrial Ablation Techniques 2Anesthesia, General 2pirfenidone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Leiomyoma × Ropivacaine × Clear all
NCT02270255 2019-08-14

Superior Hypogastric Nerve Block for Pain Control Post-uterine Fibroid Embolization

McGill University Health Centre/Research Institute of the McGill University Health Centre

Phase 2 Completed
44 enrolled 8 charts

Agnosia, Leiomyoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡